| 英文别名 |
2H-Pyran-2-one,5,6-dihydro-6-[(1E)-2-phenylethenyl]-, (6R)-;(R)-(+)-goniothalamin;Goniothalamin;(6R)-(+)-Goniothalamin;(6R)-6-[(E)-2-phenylethenyl]-5,6-dihydro-2H-pyran-2-one;2H-Pyran-2-one, 5,6-dihydro-6-(2-phenylethenyl)-, (S-(E))- (9CI);2H-Pyran-2-one, 5,6-dihydro-6-styryl-, (5S)-(+)-;CCRIS 9005;Goniothalamine;(R)-Goniothalamin;(6R)-(+)-5,6-Dihydro-6-styryl-2-pyrone;[
"(R)-(+)-Goniothalamin"
];(6R)-6α-[(E)-Styryl]-5,6-dihydro-2H-pyran-2-one;[R,(+)]-5,6-Dihydro-6α-[(E)-2-phenylethenyl]-2H-pyran-2-one;(2R)-2-[(E)-styryl]-2,3-dihydropyran-6-one;22639-28-7;(R)-goniothalamin;2H-Pyran-2-one, 5,6-dihydro-6-[(E)-2-phenylethenyl]-, (6R)-;NSC104956;SCHEMBL12444498;DTXSID801035678;FS-9350;HY-N3968;2H-Pyran-2-one, 5,6-dihydro-6-(2-phenylethenyl)-, (S-(E))-;UNII-34W9GO6B2Z;STYRYLDIHYDROPYRAN;Q27256393;17303-67-2;(2R)-2-[(E)-2-phenylethenyl]-2,3-dihydropyran-6-one;AKOS032948430;(R)-(+)-Goniothalamin;CHEMBL464443;(6R)-6.ALPHA.-((E)-STYRYL)-5,6-DIHYDRO-2H-PYRAN-2-ONE;NSC-104956;(6R)-6-[(1E)-2-phenylethenyl]-5,6-dihydro-2H-pyran-2-one;34W9GO6B2Z;CS-0024535;goniothalamin;(+)-Goniothalamin;(+) goniothalamin |